Search
Find a company, briefing, or insight.
Search covered companies, result briefings, and cross-company reports.
40 results for "Healthcare"
Insights
Companies
PHL · Healthcare / Aged care · 5 briefings
Promisia Healthcare
FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read
FPH · Healthcare / Medical devices · 7 briefings
Fisher & Paykel Healthcare
FPH capex nearly doubled to NZ$195.2m, compressing FCF conversion
RYM · Healthcare / Retirement living · 7 briefings
Ryman Healthcare
Free cash flow swings to +NZ$188m as EBITDAF nearly doubles
OCA · Healthcare / Retirement living · 7 briefings
Oceania Healthcare
OCA swung to PBT positive but capex jumped 82% to 40.4% of revenue
RUA · Healthcare / Medicinal cannabis · 8 briefings
Rua Bioscience
Revenue rose 93.5% while borrowings climbed 55.9%
SUM · Healthcare / Retirement living · 8 briefings
Summerset Group Holdings
Underlying profit fell 3% while statutory PBT jumped 63.1%
EBO · Healthcare / Healthcare distribution · 6 briefings
EBOS Group
Cash conversion fell to 58.3% while tax relief lifted NPAT, PBT down 1.0%
PEB · Healthcare / Diagnostics · 5 briefings
Pacific Edge
Revenue nearly halved as losses and cash burn both deepened
GXH · Healthcare / Pharmacy and health services · 7 briefings
Green Cross Health
Medical services-led NPAT growth of 27.5% on 4.2% revenue lift
TAH · Healthcare / Primary healthcare · 4 briefings
Third Age Health Services
PBT up 25.7% on ARC scale, full-year dividend reset to 8.0c
TRU · Healthcare / Medical diagnostics · 4 briefings
Truscreen Group
Revenue up 42% but missed $2.8m guidance as debtors swelled to $1.0m
BLT · Healthcare / Biotechnology · 8 briefings
BLIS Technologies
Revenue up 16% but working-capital absorption turned operating cash flow
RAD · Healthcare / Aged care · 7 briefings
Radius Residential Care
PBT up 36.2% and cash conversion at 91.8% as capex more than doubled
Briefings
PHL · FY26
FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read
Full-year Cromwell consolidation and a sharp H2 earnings swing lift reported NPAT while net debt/EBITDAF falls to 5.8x.
FPH · FY26
FPH capex nearly doubled to NZ$195.2m, compressing FCF conversion
Operating cash flow rose to NZ$663.2m and cash built to NZ$461.1m, but capex hit 8.5% of revenue and FCF/NPAT fell to 95.3%.
RYM · FY26
Free cash flow swings to +NZ$188m as EBITDAF nearly doubles
Operating momentum is real but Ryman remains loss-making at the PBT line, and the FCF swing is partly capex-driven rather than purely earnings-led.
RYM · HY26
PBT collapsed 123% to a NZ$40.2m loss as debt fell NZ$928m
Maiden NZ$56.2m FCF and the balance sheet reset frame the upside, but a NZ$152.7m receivables release flatters the cash result.
FPH · HY26
FPH PBT margin reached 26.1%, lifting profit 37.5% on 14.4% revenue growth
Operating leverage pushed margins above the recent historical range even as FCF conversion eased from 110.6% to 81.3% of NPAT.
OCA · HY26
OCA swung to PBT positive but capex jumped 82% to 40.4% of revenue
EBITDA rose 7.4% on flat revenue and PBT turned positive at $1.0m, but a doubled investment cycle kept free cash flow at -$8.4m.
RYM · FY25
EBITDAF tripled to $45.5m but NPAT loss widened to -$436.8m
Operating recovery is overshadowed by a capex surge to 70.4% of revenue and a -$94.2m free cash outflow.
FPH · FY25
Operating cash flow more than doubled to $548.6m as capex normalised
Revenue crossed $2.0bn for the first time and FCF reached 113.3% of NPAT, signalling earnings backed by cash after years of heavy capex.
OCA · FY25
Capex jumped 354% to $132.4m, pushing FCF to -$22.1m
EBITDA rose 4.1% and a tax credit held NPAT, but a major capex step-up consumed operating cash and net debt sits at 7.2x EBITDA.
FPH · HY25
FPH PBT up 46.8% as capex normalisation swings FCF positive
Operating leverage delivered above-baseline earnings growth while capex falling 80% to NZ$55.1m rebuilt FPH into a net cash position.
RYM · HY25
PBT up 21.9% but NPAT fell 49.4% on a tax-rate flip
A tax line that flipped from +30.2% to -46.0% drove the NPAT divergence while pre-lease free cash flow stayed below the historical range at -$52.5m.
OCA · HY25
Underlying EBITDA up 2.7% but reported result swung to NZ$17.1m NPAT loss
Operating cash flow surged on a NZ$101m receivables collection while items below EBITDA pushed PBT down 160.3% to a NZ$19.5m loss.
PHL · FY24
PBT surged on a 25.6% revenue lift driven by prior-year acquisition
Revenue growth of 25.6% flatters the comparison because FY23 included a major acquisition, while a negative effective tax rate of -54.6% inflates
OCA · FY24
Capex cut 68% to manage 7.7x leverage; tax benefit inflated NPAT
EBITDA rose just 3.2% on 7.4% revenue growth, while a -10.9% effective tax rate drove NPAT up 104.5% and development capex was paused.
FPH · HY24
Capex doubled to 34.3% of revenue, pre-lease FCF swung to NZ$127.5m negative
Revenue grew 16.4% and PBT 23.0%, but a doubled capex bill drove pre-lease FCF NZ$258.5m below the historical mean and left the dividend uncovered.
RYM · HY24
Dividend suspended as FCF stays $158.4m negative, PBT falls 34%
Headline NPAT declines just 3.8% on a 30.2% tax credit, but underlying profit is flat and pre-lease cash flow sits well below the historical range.
PHL · HY24
Revenue up 10.7% but PBT swung to a NZ$0.1m loss as costs outpaced growth
Promisia's aged-care operations grew the top line solidly, but earnings turned negative as cost growth absorbed the revenue gain, leaving a NPAT loss
OCA · HY24
NPAT swung to NZ$35.2m but trade debtors expanded NZ$110.5m
Underlying EBITDA held near NZ$37.6m, but receivables expanded NZ$110.5m and debtor days hit 168.5 against a historical mean of 22.7 days.
PHL · FY23
PBT fell 73.7% as revenue growth failed to offset cost expansion
A 25.5% revenue uplift was more than consumed by higher operating costs, lifting net debt to EBITDA to 8.0x and compressing PBT to NZ$0.5m.
FPH · FY23
FY23 FCF collapsed to $12.5m as capex stepped up 53%
H2 revenue rebounded 14%, but a 40.5c full-year dividend ran well past FCF cover with capex intensity climbing to 13.4% of revenue.
OCA · FY23
Net debt/EBITDA jumped to 6.9x as operating cash fell 33%
Revenue grew 6.9% and care swung to profit, but borrowings rose $177.9m and a $86.9m receivables build absorbed underlying cash generation.
FPH · HY23
Working capital absorbed NZ$58.7m, draining operating cash to NZ$1.9m
Revenue fell 23.3% on post-COVID normalisation, but a NZ$58.7m working-capital build left the lifted dividend uncovered by free cash flow.
RYM · HY23
NZ$281m working-capital build cut pre-lease FCF to NZ$51.8m as NPAT fell 31%
Underlying profit rose 44.8% but reported NPAT fell 31.1% as receivables expanded and capex jumped 56%, draining cash flow despite revenue growth.
OCA · HY23
PBT fell 74.3% on lower Village revaluations as cash conversion slid
Realised sales gains rose 12%, but cash conversion dropped to 81.2% and the 1.9c dividend exceeds NPAT cover.
PHL · FY22
First full year of acquired aged-care lifts revenue to $19.0m
Headline +213.6% growth reflects the December 2020 acquisition lapping into a full period, not underlying expansion of the existing footprint.
RYM · FY22
Reported NPAT jumped 63.8% but underlying profit grew only 13.6%
Investment property revaluations drove the headline gain while capex at 55.9% of revenue absorbed most of the operating cash flow expansion.